Steffen Rosén

CEO
Rossix
Sweden

Business Expert Haematology
Biography

Steffen Rosén has a background as PhD in biochemistry and started his career at Kabi Diagnostica 1978. He expanded the bioreagent purification and was responsible for the development of Coatest Factor VIII, the first chromogenic FVIII kit. He became head of coagulation research and later Director R&D and VP Scientific and Medical Affairs at Chromogenix. Under his guidance, several chromogenic kits in coagulation and fibrinioysis were developed as well as the clotting based Coatest APC Resistance Kit. Steffen was also the technical expert in patent matters at Chromogenix. Steffen Rosén has more than 30 ​years experience from his work at Kabi Diagnostica and later Chromogenix in development of methods and products in Hemostasis. In 2000 Steffen founded the company Rossix

Research Intrest

Steffen Rosén has more than 30 ​years experience from his work at Kabi Diagnostica and later Chromogenix in development of methods and products in Hemostasis